Data and safety monitoring committees in clinical trials /
Saved in:
| Author / Creator: | Herson, Jay. |
|---|---|
| Imprint: | Boca Raton, FL : Chapman & Hall/CRC, c2009. |
| Description: | xviii, 173 p. : ill. ; 25 cm. |
| Language: | English |
| Series: | Chapman & Hall/CRC biostatistics series ; 30 |
| Subject: | Drugs -- Testing -- Evaluation. Drugs -- Testing -- Statistical methods -- Evaluation. Clinical Trials Data Monitoring Committees -- organization & administration. Clinical Trials as Topic -- standards. Data Collection. Drug Industry -- standards. Research Design. Safety Management. |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/7733614 |
| LEADER | 02192cam a22004694a 4500 | ||
|---|---|---|---|
| 001 | 7733614 | ||
| 003 | ICU | ||
| 005 | 20100127152300.0 | ||
| 008 | 090127s2009 flua b 001 0 eng | ||
| 010 | |a 2009003127 | ||
| 020 | |a 9781420070378 (hardcover : alk. paper) | ||
| 020 | |a 1420070371 (hardcover : alk. paper) | ||
| 035 | |a 2009003127 | ||
| 035 | |a (OCoLC)166872492 | ||
| 040 | |a DNLM/DLC |c DLC |d YDX |d NLM |d BTCTA |d BAKER |d YDXCP |d UtOrBLW | ||
| 042 | |a pcc | ||
| 050 | 0 | 0 | |a RM301.27 |b .H47 2009 |
| 060 | 1 | 0 | |a QV 771 |b H572d 2009 |
| 082 | 0 | 0 | |a 615/.19 |2 22 |
| 100 | 1 | |a Herson, Jay. |0 http://id.loc.gov/authorities/names/n2009180361 |1 http://viaf.org/viaf/61031991 | |
| 245 | 1 | 0 | |a Data and safety monitoring committees in clinical trials / |c Jay Herson. |
| 260 | |a Boca Raton, FL : |b Chapman & Hall/CRC, |c c2009. | ||
| 300 | |a xviii, 173 p. : |b ill. ; |c 25 cm. | ||
| 336 | |a text |b txt |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a unmediated |b n |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/n | ||
| 338 | |a volume |b nc |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/nc | ||
| 440 | 0 | |a Chapman & Hall/CRC biostatistics series ; |v 30 | |
| 504 | |a Includes bibliographical references (p. 155-166) and index. | ||
| 505 | 0 | |a Introduction -- Organization of a safety monitoring program for a confirmatory trial -- Meetings -- Clinical issues -- Statistical issues -- Bias and pitfalls -- Data monitoring committee decisions -- Emerging issues. | |
| 650 | 0 | |a Drugs |x Testing |x Evaluation. | |
| 650 | 0 | |a Drugs |x Testing |x Statistical methods |x Evaluation. | |
| 650 | 1 | 2 | |a Clinical Trials Data Monitoring Committees |x organization & administration. |
| 650 | 1 | 2 | |a Clinical Trials as Topic |x standards. |
| 650 | 2 | 2 | |a Data Collection. |
| 650 | 2 | 2 | |a Drug Industry |x standards. |
| 650 | 2 | 2 | |a Research Design. |
| 650 | 2 | 2 | |a Safety Management. |
| 903 | |a HeVa | ||
| 929 | |a cat | ||
| 999 | f | f | |i 53b47cdc-7a04-52ab-a826-02d3fe45975a |s 7e0fd2da-96a6-5b7f-8598-93126fe4ad01 |
| 928 | |t Library of Congress classification |a RM301.27 .H47 2009 |l JCL |c JCL-Sci |i 5473758 | ||
| 927 | |t Library of Congress classification |a RM301.27 .H47 2009 |l JCL |c JCL-Sci |e CRERAR |b 089356666 |i 8626151 | ||
